ITGA6 has two variants: α6A and α6B, with past studies suggesting that the α6A isoform does not maintain tumor stem cell function (Goel et al., 2014), while breast cancer cells with high expression of integrin α6Bβ1 exhibit CSC characteristics (Chang et al., 2015). This evidence concerns the gene ITGA6 and neoplasm.